Reference Sachs, Harnke, Mehler and Krantz14Reference Stheneur, Bergeron and Lapeyraque18 Myocardial atrophy results in reduced cardial mass, reduced cardiac chamber volumes, mitral valve prolapse and myocardial fibrosis which leads to reduced cardiac output and lower blood pressure
In this trial, the weight increase for insulin glargine was independent of baseline BMI, whereas the weight loss for semaglutide 1.0 mg was BMIdependent, leading to a significant interaction ( P = .0046)
Studies show IGF-1 supports cognitive function, combats neurodegenerative processes, and enhances synaptic formation and autophagy
Tesamorelin is a GHRH analog that stimulates pituitary release of growth hormone, driving lipolysis specifically in visceral adipose tissue
A weight loss stall happens when progress slows or stops despite ongoing treatment